Interestingly, according to studies, in keloid, one of the benign skin tumors [63], ADSCs could reduce the expression of COL1A1 in keloid fibroblasts and deposition of collagen in keloid tissue ex vivo. This evidence concerns the gene COL1A1 and benign neoplasm of skin.